Ruxolitinib + NAVITOCLAX

2 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Ruxolitinib + NAVITOCLAX
Treatment and conditionWhere it standsTrials
Ruxolitinib + NAVITOCLAX for neoplasmsPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Ruxolitinib + NAVITOCLAX for primary myelofibrosisPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1